10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2017

Filing Information

Form Type	10-Q
Accession Number	`0001213900-17-005185`
Period End Date	20170331
Filing Date	20170515
Fiscal Year	2017
Fiscal Period	Q3
XBRL Instance	rlmd-20170331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 52 Cash Flow Statement 50

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.35M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.76M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$486.90K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$798.09K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$9.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.24M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$511.82K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$531.35K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$415.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$414.36K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.04M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.04M	shares	Point-in-time
Total assets	`Assets`	$4.17M	USD	Point-in-time
Total assets	`Assets`	$10.24M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$335.43K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$586.44K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$634.85K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$27.58K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$273.67K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$892.50K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$279.43K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.23M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.06M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$140.91K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$139.42K	USD	Point-in-time
Total liabilities	`Liabilities`	$1.37M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.20M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,039,912 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 12,039,912 and 12,035,037 shares issued and outstanding, respectively	`CommonStockValue`	$12.04K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$86.54M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-79.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-83.75M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$7.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$2.80M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$4.17M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$10.24M	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$609.12K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.11M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$490.69K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.59M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.33M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.52M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.14M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.28M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$13.11M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$5.44M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$2.75M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.28M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-13.11M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.75M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-5.44M	USD	3 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$831.97K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$13.39M	USD	3 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$613.07K	USD	3 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$244.07K	USD	1 Quarter
Net interest income (expense)	`InterestIncomeExpenseNonoperatingNet`	$778.00	USD	1 Quarter
Net interest income (expense)	`InterestIncomeExpenseNonoperatingNet`	$473.00	USD	1 Quarter
Net interest income (expense)	`InterestIncomeExpenseNonoperatingNet`	$-756.00	USD	3 Qtrs
Net interest income (expense)	`InterestIncomeExpenseNonoperatingNet`	$-149.00	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$56.91K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$54.56K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$68.66K	USD	3 Qtrs
Other income	`OtherNonoperatingIncome`	$170.73K	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$301.46K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$887.31K	USD	1 Quarter
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$13.46M	USD	3 Qtrs
Total other income (expenses)	`OtherNonoperatingIncomeExpense`	$783.04K	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-1.98M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-4.65M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-1.86M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$342.70K	USD	3 Qtrs
Net (loss) income per common share - basic	`EarningsPerShareBasic`	$-0.39	USD	3 Qtrs
Net (loss) income per common share - basic	`EarningsPerShareBasic`	$-0.16	USD	1 Quarter
Net (loss) income per common share - basic	`EarningsPerShareBasic`	$-0.15	USD	1 Quarter
Net (loss) income per common share - basic	`EarningsPerShareBasic`	$0.03	USD	3 Qtrs
Net (loss) income per common share - diluted	`EarningsPerShareDiluted`	$-0.39	USD	3 Qtrs
Net (loss) income per common share - diluted	`EarningsPerShareDiluted`	$0.03	USD	3 Qtrs
Net (loss) income per common share - diluted	`EarningsPerShareDiluted`	$-0.16	USD	1 Quarter
Net (loss) income per common share - diluted	`EarningsPerShareDiluted`	$-0.15	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	11.46M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.04M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.04M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.00M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.04M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.00M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.14M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.04M	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net (loss) income	`NetIncomeLoss`	$-1.98M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$-4.65M	USD	3 Qtrs
Net (loss) income	`NetIncomeLoss`	$-1.86M	USD	1 Quarter
Net (loss) income	`NetIncomeLoss`	$342.70K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$67.01K	USD	3 Qtrs
Depreciation expense	`Depreciation`	$33.48K	USD	3 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	-	USD	3 Qtrs
Common stock issued for services	`CommonStockIssuedForServices`	$204.53K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$412.58K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$847.76K	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-13.39M	USD	3 Qtrs
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$-613.07K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-1.06M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpensesOther`	$-310.54K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-924.28K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-91.12K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-48.41K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$563.43K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$108.98K	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.49K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-10.32M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.45M	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$539.21K	USD	3 Qtrs
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$47.49K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.49K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-539.21K	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$263.75K	USD	3 Qtrs
Principal payments of note payable	`RepaymentsOfNotesPayable`	$246.09K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-263.75K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-246.09K	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-11.12M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-5.74M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$11.35M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.76M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$11.35M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$8.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.76M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$22.47M	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Interest	`InterestPaid`	$2.65K	USD	3 Qtrs
Interest	`InterestPaid`	$2.65K	USD	3 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfInsurancePremiumsByIssuanceOfNotePayable`	$263.75K	USD	3 Qtrs
Financing of insurance premiums by issuance of note payable	`FinancingOfInsurancePremiumsByIssuanceOfNotePayable`	-	USD	3 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$72.00	USD	3 Qtrs
Conversion of Class A convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	3 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	-	USD	3 Qtrs
Issuances of common stock resulting from cashless exercise of warrants	`StockIssued1`	$1.09K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.